戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 SIGN: Multicenter non-inferiority randomised controlled clinical trial.
2                          Design: Randomized, controlled clinical trial.
3 a booster aP vaccine dose in this randomized controlled clinical trial.
4 nd, prospective, non-inferiority, randomised controlled clinical trial.
5 s syndrome deserving of a randomized placebo controlled clinical trial.
6  The DCCT was a large multicenter randomized controlled clinical trial.
7 ey have not been validated in a prospective, controlled clinical trial.
8 treatment, through a parallel-group, placebo-controlled clinical trial.
9 tage CHL in a multicenter phase 3 randomized controlled clinical trial.
10 study is a randomized, double-blind, placebo-controlled clinical trial.
11 cessions (REC), in a prospective randomized, controlled clinical trial.
12 ent has never been subjected to a randomized controlled clinical trial.
13 riodontal pockets, in a double-blind placebo-controlled clinical trial.
14 RTICIPANTS: Multicenter, randomized, placebo-controlled clinical trial.
15        Prospective, randomized, multicenter, controlled clinical trial.
16     Eighteen-month, multicenter, randomized, controlled clinical trial.
17 lticenter, randomized, double-blind, placebo-controlled clinical trial.
18            Randomized, double-blind, placebo-controlled clinical trial.
19 spective, 24-month, dose-ranging, paired-eye controlled clinical trial.
20                       Prospective randomized controlled clinical trial.
21 be further explored in a randomised, placebo-controlled clinical trial.
22           Randomized, double-masked, placebo-controlled clinical trial.
23 currently being tested in randomized placebo-controlled clinical trials.
24  should be investigated in future randomized controlled clinical trials.
25  rigor analogous to multicenter, randomized, controlled clinical trials.
26 Proof of efficacy awaits randomized, placebo-controlled clinical trials.
27  PDT yielded comparable outcomes as those of controlled clinical trials.
28 38 Dutch volunteers enrolled in 2 randomized controlled clinical trials.
29    This represents the basis for forthcoming controlled clinical trials.
30 , body mass index, or waist circumference in controlled clinical trials.
31 nts, however, has to be further evaluated in controlled clinical trials.
32 nt of the impact of this intervention awaits controlled clinical trials.
33  was higher than previously reported in well-controlled clinical trials.
34 tifications are based on dedicated, strictly controlled clinical trials.
35 nalysis of the VISUAL-1 and VISUAL-2 placebo-controlled clinical trials.
36 6 randomized, double-masked, sham- and laser-controlled clinical trials.
37  are experimentally determined in randomised controlled clinical trials.
38  in depressed patients in randomised placebo-controlled clinical trials.
39  apple were included in an open, randomized, controlled clinical trial: 27 patients consumed daily de
40                     In a randomized, placebo-controlled clinical trial, 40 participants received 1000
41               In a double-blinded randomized controlled clinical trial, 44 mothers with active caries
42                                         In a controlled clinical trial, 48 patients (mean age 50 +/-
43                    There are few randomized, controlled clinical trials about the effect of non-surgi
44                  Few prospective, randomized controlled clinical trials address the diagnosis and man
45       In a randomized double-blinded placebo-controlled clinical trial, adults with grass pollen-indu
46  studies, with six randomised, double-blind, controlled clinical trials, all of which investigated ve
47 onducted a randomized, double-blind, placebo-controlled clinical trial among pregnant women presentin
48        Here, we performed a randomized, sham-controlled clinical trial and measured electrophysiologi
49 lementation should be tested in a randomized controlled clinical trial and that the analysis should i
50 rognostic value of NT-proBNP thresholds in a controlled clinical trial and to evaluate the response t
51 mpliant, randomized, double-blinded, placebo-controlled clinical trial, and all patients provided inf
52 udies included randomised controlled trials, controlled clinical trials, and cohort studies; their ov
53         Finally, 11 studies (eight RCTs, two controlled clinical trials, and one retrospective study)
54 iteria: randomized controlled trials (RCTs), controlled clinical trials, and prospective clinical stu
55 , PsycINFO, the Cochrane Central Register of Controlled Clinical Trials, and the Cochrane Database of
56 not the high efficacy reported in randomised controlled clinical trials are materialising in real-wor
57                   Moving forward, randomized controlled clinical trials are necessary to ensure that
58 cute liver failure, multicenter, randomized, controlled clinical trials are needed to confirm that hy
59                           More well designed controlled clinical trials are needed which use phytoche
60 wever, long-term, multicentered, randomized, controlled clinical trials are required to know the clin
61                                              Controlled clinical trials are under way to assess the e
62 lable which require evaluation in randomized controlled clinical trials as adjunct therapies for shor
63 s compared to classical double-blind placebo-controlled clinical trials as the basis for precise pers
64               This double-blind, randomized, controlled clinical trial assessed the efficacy of multi
65 rallel-group, forced dose titration, placebo-controlled clinical trial at 30 sites from May 10, 2011,
66 , multicenter, randomized, active comparator-controlled, clinical trial at multiple locations of the
67 us study, a randomized double-blind, placebo-controlled clinical trial, between August 2003 and Novem
68 c reviews (SRs), randomized clinical trials, controlled clinical trials, case series, and case report
69  the PubMed and Cochrane Central Register of Controlled Clinical Trials (CENTRAL) search engines from
70 ed MEDLINE, the Cochrane Central Register of Controlled Clinical Trials, ClinicalTrials.gov, and rele
71                This prospective, randomized, controlled clinical trial compared changes in exercise p
72                      This randomized placebo-controlled clinical trial compared the response to a gin
73 onducted a randomized, double-blind, placebo-controlled clinical trial comparing apixaban, at a dose
74 (PISTE) trial was a multicentre, randomised, controlled clinical trial comparing intravenous thrombol
75        We performed a prospective randomized controlled clinical trial comparing NPWT to standard dry
76                                   Randomized controlled clinical trials comparing a strategy of promp
77 y cases, do not have support from randomised controlled clinical trials comparing bariatric surgery w
78 e present study was a split-mouth randomized controlled clinical trial comprising 20 chronic periodon
79                                              Controlled clinical trials conduct the research that com
80       In a randomized, double-blind, placebo-controlled clinical trial conducted as a pilot study, 52
81 domized, double-blind, double-dummy, placebo-controlled clinical trial conducted at 10 university cli
82 ts (FISH) study, a randomized, double-blind, controlled clinical trial conducted at 15 North American
83      Multicenter prospective, double-masked, controlled clinical trial conducted at 80 clinical sites
84 : Phase 3, randomized, double-blind, placebo-controlled clinical trial conducted at 91 clinical sites
85            Randomized, double-blind, placebo-controlled clinical trial conducted from 2008 to 2013 in
86 YNDIET study is a 6-mo randomized, parallel, controlled clinical trial conducted in 122 overweight an
87                 In this blinded, randomized, controlled clinical trial conducted over 6 months with a
88 reated with placebo in 12 randomized placebo-controlled clinical trials conducted mostly in outpatien
89 Phase 1-2, randomized, double-blind, placebo-controlled, clinical trial conducted from 2008 to 2012.
90  trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-after stud
91  trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-and-after
92  trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-and-after
93             Our phase III randomized placebo-controlled clinical trial demonstrated that naproxen at
94 he mechanisms of action of novel agents, and controlled clinical trials documenting their efficacy an
95  This retrospective analysis of five placebo-controlled clinical trials does not support a decreased
96 er and neutropenia through observational and controlled clinical trials done by single institutions,
97 uble-masked, randomized, multicenter, active-controlled clinical trial enrolled 224 eyes of 224 patie
98 , participant- and surgeon-masked randomized controlled clinical trial (EudraCT No.
99                              This randomized controlled clinical trial evaluated the effects of repea
100 xtension study of a multicenter, randomized, controlled clinical trial evaluating the effect and long
101 s performed to identify all blinded, placebo-controlled clinical trials evaluating acute selective NS
102          There is a major lack of randomized controlled clinical trials evaluating the efficacy of pr
103    Methods A systematic review of randomized controlled clinical trials evaluating weight loss interv
104 e, there is a paucity of randomised, placebo-controlled clinical trial evidence where the primary out
105         This study highlights the need for a controlled clinical trial examining the cause of the con
106                                No randomized controlled clinical trials exist to definitively support
107                         However, randomized, controlled, clinical trials failed to demonstrate benefi
108 mized, double-blind, 14- to 15-week, placebo-controlled clinical trial, followed by a 1-year open-lab
109 dence, from case reports to large randomized controlled clinical trials, for the possible adverse eff
110 -stratified multicentre, randomised, placebo-controlled clinical trial from Nov 16, 2010, to Sept 12,
111 lished when "at least two blinded randomized controlled clinical trials from two different groups of
112                                    Though no controlled clinical trial has been performed to provide
113                                  A number of controlled clinical trials have been performed to show i
114                  Phase 3 randomised, placebo-controlled clinical trials have clarified aspects of dis
115                   Numerous studies including controlled clinical trials have demonstrated that anti-T
116                                              Controlled clinical trials have identified a limited num
117                         To date, randomized, controlled clinical trials have not reproduced the effic
118                    Five studies, including 2 controlled clinical trials, have demonstrated significan
119 roup, multicenter, double-blind, randomized, controlled clinical trial in 150 adults after gastrointe
120 trial is a randomized, double-blind, placebo-controlled clinical trial in 160 patients with severe, n
121 pated in a randomized, double-blind, placebo-controlled clinical trial in 2011 and 2012 on the safety
122    We conducted a randomized, double-masked, controlled clinical trial in 225 10- to 18-y-old eligibl
123 ospective, double-blind, randomized, placebo-controlled clinical trial in an ambulatory care and home
124 dy was a pragmatic, single-centre randomised controlled clinical trial in community-dwelling individu
125                   In this Phase I randomised controlled clinical trial in HIV-1 negative volunteers w
126 hase 1b, double-blinded, randomised, placebo-controlled clinical trial in Kampala, Uganda to examine
127 -center, randomized, double-blinded, placebo-controlled clinical trial in patients undergoing emergen
128                         The first randomized controlled clinical trial in refractory adult and childh
129 ulticenter randomized, double-blind, placebo-controlled clinical trial in Tasmania and Victoria, Aust
130 r FMT in a randomized, single-blind, placebo-controlled clinical trial in Virginia.
131 a lack of long-term data and data outside of controlled clinical trials in carotid artery stenting.
132 9 disease will now be assessed in randomized controlled clinical trials in humans.
133 herapies have been shown to be of benefit in controlled clinical trials in humans.
134                                 We recommend controlled clinical trials in patients with ICUAW that c
135                   Basic research, as well as controlled clinical trials, in this realm offers promisi
136                                      Sixteen controlled clinical trials, including more than 3000 chi
137 hrough population-based studies and in large controlled clinical trials; inflammatory marker levels a
138               Randomized, controlled trials; controlled clinical trials; interrupted time series; and
139            Randomized, double-blind, placebo-controlled clinical trials investigating the efficacy of
140 lticenter, double-blind, randomized, placebo-controlled clinical trial involving 114 North American e
141             A randomized, double-blind, sham-controlled clinical trial involving 239 participants who
142 d be required to mount a randomized, placebo-controlled clinical trial involving premanifest HD indiv
143 ruvada) has demonstrated efficacy in placebo-controlled clinical trials involving men who have sex wi
144 xtends beyond the skin and that a randomized controlled clinical trial is needed to confirm these fin
145                                 A randomized controlled clinical trial is the best way to minimize bi
146                               The randomized controlled clinical trial is the gold standard scientifi
147                  The aim of this randomized, controlled clinical trial is to determine whether ridge
148           Further evaluation in a randomized controlled clinical trial is warranted to test for effic
149 st evidence from population-level randomized controlled clinical trials is lacking.
150              Double-blind randomized placebo-controlled clinical trials lasting >=7 days were include
151                                            A controlled clinical trial may be warranted.
152 he largest randomized, double-blind, placebo controlled clinical trial, now underway, designed to eva
153                The trial was registered with Controlled Clinical Trials (number ISRCTN76894700).
154       Medline was searched to identify RCTs, controlled clinical trials, observational studies, case
155                   We conducted a randomized, controlled clinical trial of a peer mentoring interventi
156 r herpesviruses in this disease is through a controlled clinical trial of an efficacious antiviral dr
157                    However, a recent placebo-controlled clinical trial of AV-101 in depression found
158 d as neonates in a double-blind, randomized, controlled clinical trial of caffeine versus placebo und
159   This was a double-blind randomized placebo-controlled clinical trial of creatine monohydrate (10 g/
160                   No double-blinded, placebo controlled clinical trial of curcumin has been successfu
161 cted a prospective, multicenter, randomized, controlled clinical trial of diabetic patients to invest
162                         A randomized placebo-controlled clinical trial of dietary phosphatidylcholine
163                  Population-based randomized controlled clinical trial of first graders from 44 schoo
164 lticenter, randomized, double-blind, placebo-controlled clinical trial of hydroxyurea in infants (beg
165   In 2013 we conducted a randomized, placebo-controlled clinical trial of live attenuated influenza v
166 st intermediate AMD enrolled in a randomized controlled clinical trial of lutein/zeaxanthin and/or om
167 igh-quality phenotype data from a randomized controlled clinical trial of nAMD.
168                           In this randomized controlled clinical trial of patients with acute iliofem
169 were obtained from subjects during a placebo-controlled clinical trial of peanut OIT.
170 lticenter, randomized, double-blind, placebo-controlled clinical trial of peanut sublingual immunothe
171 -blinded, placebo-randomized, within-subject controlled clinical trial of single and multiple ascendi
172 ospective, double-blind, randomized, placebo-controlled clinical trial of the effects of 5 smoking ce
173 ples ascertained through the largest placebo-controlled clinical trial of the monoamine oxidase B inh
174 r, randomized, single-masked, sham-injection controlled clinical trial of the safety, tolerability, a
175 tudy was a randomized, double-blind, placebo-controlled clinical trial of vitamin D3 supplementation
176                                              Controlled clinical trials of anti-acid treatments are n
177          Several relatively small randomized controlled clinical trials of anticoagulation as cancer
178                                   Randomized controlled clinical trials of BT in severe asthma have n
179                         Data from rigorously controlled clinical trials of convalescent plasma are al
180                             Three randomized controlled clinical trials of fasting in humans were ide
181     We carried out two double-blind, placebo-controlled clinical trials of N-methyl-D-aspartate recep
182  a meta-analysis of English language placebo-controlled clinical trials of naloxone, naltrexone, nalm
183 int that should be used in future randomized controlled clinical trials of novel therapies in idiopat
184 6810), two phase 3, double-blind, randomised controlled clinical trials of the HPV-16/18 AS04-adjuvan
185 ase pathogenesis and knowledge provided from controlled clinical trials of these new therapeutic agen
186 oled analysis of weight gain in 8 randomized controlled clinical trials of treatment-naive people liv
187 oled analysis of weight gain in 8 randomized controlled clinical trials of treatment-naive people wit
188                                   Randomized controlled clinical trials offer the best evidence for c
189 blind, household-cluster-randomized, placebo-controlled clinical trial on Flores island, Indonesia, a
190 randomized, crossover, double-blind, placebo-controlled clinical trial on human immunodeficiency viru
191 o treat mast cell mediator-related symptoms, controlled clinical trials on how they improve quality o
192 d studies were randomized controlled trials, controlled clinical trials, or cohort studies with 10 or
193 IGN: In a multicenter prospective randomized controlled clinical trial, patients with GD were randomi
194 level of evidence of treatments based on the controlled clinical trials performed with each compound
195   This randomized, double-blind, prospective controlled clinical trial (phase 2B) was designed to inv
196 rechallenge, additional data are needed from controlled clinical trials, prospective registries, and
197 th blood pressure (BP) levels and randomized controlled clinical trials providing evidence of stroke
198                              This randomized controlled clinical trial (RCT) called for 120 participa
199 stematically reviewed to identify randomized controlled clinical trials (RCTs) in chronic heart failu
200 ual patient data meta-analysis of randomized controlled clinical trials (RCTs) to evaluate whether ba
201                                   Randomized controlled clinical trials (RCTs), prospective cohort st
202 hest level of evidence comes from randomized controlled clinical trials (RCTs).
203 s phase 2, randomised, double-blind, placebo-controlled clinical trial recruited patients aged 18-65
204                                   Randomized controlled clinical trials remain the best method for mi
205 ICIPANTS: Multicenter, double-blind, placebo-controlled clinical trial (Renal Optimization Strategies
206 ncludes a review of split-mouth, randomized, controlled clinical trial results that specifically trac
207  polyneuropathy, according to recent placebo-controlled clinical trial results.
208  as efficacy can change when moving from the controlled clinical trial setting to clinical practice.
209  to these drugs in clinical care, outside of controlled clinical trial settings.
210 ants: 29 randomized controlled trials, seven controlled clinical trials, seven consecutive case serie
211 long-term follow-up of a randomized, placebo-controlled, clinical trial (SHEP) of patients aged 60 ye
212 monly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmona
213                 Results of recent randomized controlled clinical trials suggest that most patients wi
214                                     A recent controlled clinical trial suggested a role for amantadin
215                           However, there are controlled clinical trials suggesting its efficacy in ot
216  is a large body of evidence from randomized controlled clinical trials supporting the cardiovascular
217 as a prospective, single-blinded, randomized controlled clinical trial testing the hypothesis that he
218 k Trial), a randomized, double-blind, active-controlled clinical trial that enrolled hypertensive ind
219 I) 53 is a randomized, double-blind, placebo-controlled clinical trial that evaluated the safety of s
220 he ICTUS trial was a multicenter, randomized controlled clinical trial that included 1,200 patients w
221        Eight searches were performed seeking controlled clinical trials that addressed the ability of
222  review was conducted to identify randomised controlled clinical trials that assessed the use of poly
223 , prospective, retrospective, and randomized controlled clinical trials that evaluated implant stabil
224 ked, multicenter, randomized, sham injection-controlled clinical trials that evaluated intravitreal l
225 ive search strategies to identify randomized controlled clinical trials that evaluated the effects of
226                                   Randomized controlled clinical trials that evaluated the efficacy o
227 ed and inconsistent evidence from randomized controlled clinical trials that greater PAC involvement
228 tudies and post hoc analyses from randomized controlled clinical trials that provided data on the out
229                     Prospective, randomized, controlled clinical trials that reported isoniazid acety
230 tudy was a randomized, double-blind, placebo-controlled, clinical trial that accrued subjects from fi
231   Here we show-in two independent randomized controlled clinical trials-that metformin increases circ
232 les from a randomized, double-blind, placebo-controlled clinical trial (the Vitamin D Antenatal Asthm
233 eing evaluated prospectively in a randomized controlled clinical trial, the AREDS2.
234                          In this randomized, controlled clinical trial, the questionnaires Oral Impac
235 that we discuss need to be validated in well-controlled clinical trials, these new discoveries regard
236                          We did a randomised controlled clinical trial to assess the efficacy and saf
237                   We conducted a randomized, controlled clinical trial to assess the safety and effic
238 n the context of a randomized, double-blind, controlled clinical trial to assess whether cowpea or co
239     We conducted a randomized, double-blind, controlled clinical trial to determine whether hyperbari
240        METHODS AND We performed a randomized controlled clinical trial to evaluate the effect of high
241 STUS (Open-Label, 2x2 Factorial, Randomized, Controlled Clinical Trial to Evaluate the Safety of Apix
242 y (AREDS) is the only large-scale randomized controlled clinical trial to show a 25% beneficial effec
243 orm management of Legionnaires' disease, and controlled clinical trials to ascertain the optimum anti
244   The objective was to combine evidence from controlled clinical trials to assess the effect of n-3 L
245 sed of several histological types, rendering controlled clinical trials to establish the best treatme
246 nge will be to design prospective randomized controlled clinical trials to provide the evidence neces
247 f patients who would have been excluded from controlled clinical trials undergoes carotid artery sten
248  Data from a randomized double-blind placebo-controlled clinical trial undertaken in healthy young ad
249 le-center, randomized, double-blind, placebo-controlled clinical trial was conducted at Siriraj Hospi
250        A prospective, randomized, fellow-eye-controlled clinical trial was conducted at the Byers Eye
251          A randomized, double-blind, placebo-controlled clinical trial was conducted between May 7, 2
252 is 12-week double-blind, randomized, placebo-controlled clinical trial was conducted from February 1,
253             A 6-month randomized and placebo-controlled clinical trial was conducted in 171 postmenop
254 A 12-week, randomized, double-blind, placebo-controlled clinical trial was conducted in 50 unpaid tre
255       This randomized, double-blind, placebo-controlled clinical trial was conducted in 54 women with
256          A randomized, double-blind, placebo-controlled clinical trial was conducted in HV (n = 54) a
257                    A single-blind randomized controlled clinical trial was conducted in southern Mala
258 lend.A prospective, double-blind, randomized controlled clinical trial was conducted in which childre
259                                 A randomized controlled clinical trial was conducted to compare the e
260                                            A controlled clinical trial was conducted to determine the
261  an 8-week randomized, double-blind, placebo-controlled clinical trial was conducted.
262 pective, randomized, placebo, and positively controlled clinical trial was designed to evaluate the c
263                                            A controlled clinical trial was done in young adult volunt
264 le neutralizing antibody response, a placebo-controlled clinical trial was performed in 48 healthy ad
265          A randomized, double-blind, placebo-controlled clinical trial was performed in 70 women with
266                           A pilot randomized controlled clinical trial was performed to evaluate the
267                     A randomized "two armed" controlled clinical trial was performed.
268            The hypothesis of this randomized controlled clinical trial was that local application of
269 ackground: The aim of the present randomized controlled clinical trial was to assess the bucco-lingua
270             The objective of this randomized controlled clinical trial was to assess the efficacy of
271         The goal of this 12-month randomized controlled clinical trial was to compare three-dimension
272     The purpose of this multicenter randomly controlled clinical trial was to compare two acellular d
273                              The aim of this controlled clinical trial was to determine clinical appl
274          The primary aim of this randomized, controlled clinical trial was to determine the efficacy
275 e purpose of this single-masked, randomized, controlled clinical trial was to evaluate the effects of
276 KEEPS, a randomized, double-blinded, placebo-controlled clinical trial, was conducted at nine US acad
277 especified analysis of a randomized, placebo-controlled clinical trial, we compared the differences i
278               In a double-blind, randomized, controlled clinical trial, we compared the efficacy, tol
279                In this double-blind, placebo-controlled clinical trial, we enrolled a cohort of patie
280    In this randomised, double-blind, placebo-controlled clinical trial, we enrolled children and youn
281    In this double-blind, randomized, placebo-controlled clinical trial, we evaluated systemic and muc
282 hich was a randomized, double-blind, placebo-controlled clinical trial, we explored the effectiveness
283    In this randomised, double-blind, placebo-controlled clinical trial, we recruited patients from 78
284        For this phase 2, randomised, placebo-controlled, clinical trial, we enrolled patients with re
285 spective, randomized, double-masked, placebo-controlled clinical trials were conducted at 39 ophthalm
286                                           No controlled clinical trials were identified.
287                            Prospective human controlled clinical trials were included that compared s
288       Two independent prospective randomized controlled clinical trials were performed for treatment
289                                   This was a controlled clinical trial where patients with an elevate
290 mplications data are derived from randomized controlled clinical trials, which report a high adverse
291                               Future placebo-controlled clinical trials will be required to establish
292  However, long-term, multicenter randomized, controlled clinical trials will be required to know thei
293  of preliminary studies, ongoing randomized, controlled clinical trials will potentially provide defi
294  conducted a randomized double-blind placebo-controlled clinical trial with 208 opioid-dependent pati
295                                   Randomized controlled clinical trial with 4-week follow-up that inc
296                 Randomized, blinded, placebo-controlled clinical trial with a 12-week treatment perio
297            Double-blind, randomized, placebo-controlled clinical trial with a 12-week treatment phase
298        In the present prospective randomized controlled clinical trial with three parallel arms (#NCT
299                             Uncontrolled and controlled clinical trials with different compounds and
300                                  Prospective controlled clinical trials with immunomodulatory therapy

 
Page Top